FactSet Competitors: 9 Alternatives Compared

FactSet competitors range from real-time market terminals to focused private-company data services. They are not interchangeable. The right shortlist depends on whether the buyer needs prices and news, estimates and modelling, portfolio analytics, private-company financials, registry evidence or an enterprise data feed—and which of those jobs must work together.

Commercial disclosure: Veripoint is by Global Database. Monetaiq’s legal footer identifies Global Data Intelligence Limited, the same company behind Global Database. These are affiliated offerings, not three independent endorsements. The order follows this series’ editorial format and is not an objective ranking or the result of comparative product testing.

Start by separating five different data jobs

Public-market workstations combine traded-security data, company fundamentals, estimates, research, news, portfolio tools and productivity features. FactSet, Bloomberg Terminal, LSEG Workspace and Capital IQ Pro overlap here, but the purchased data, role configuration and ecosystem can matter more than the headline platform name. Exchange entitlements, broker research and third-party datasets may have separate charges and usage restrictions.

Private-company financials begin with a legal entity and the accounts it is required or willing to disclose. The output may include revenue, earnings, assets, liabilities and cash flow, but availability varies sharply by jurisdiction, company size and reporting regime. A provider profile is not proof that full statements exist. Preserve the period, filing date, currency, units, consolidation basis, source and whether each figure is reported, calculated, estimated or unavailable.

Registry data establishes the company’s formal identity, status, officers, shareholders and filings. It can resolve whether the analyst is looking at a parent, subsidiary or similarly named entity. Registry evidence does not supply live market prices, consensus estimates or a recommended credit limit. Global Database sits closest to this identity-and-evidence layer in the shortlist.

Credit intelligence supports lending or trade-credit decisions with provider-specific scores, limits, payment behaviour, adverse events and monitoring. None of the featured institutional market platforms should automatically be treated as a credit bureau. A financial statement, security rating and commercial credit opinion answer different questions and can have different eligible populations and legal meanings.

Private-capital and emerging-market intelligence add context around investors, deals, ownership, local industries and countries. FactSet and Capital IQ Pro have expanded their private-market propositions, while EMIS specializes in emerging-market company and sector research. That context may be decisive for sourcing or diligence, but it should not be confused with a statutory filing or a live exchange feed.

Define which layer is missing before scheduling demonstrations. If the problem is an unverified private-company figure, begin with private-company financial evidence. If the problem is broad terminal procurement, use the financial research platform guide. A bigger data catalogue is not automatically the right answer to a narrower evidence gap.

Nine providers, reviewed by documented capability and limitation

Official product and pricing pages were checked independently on 21 October 2026. The comparison table and reviews use the same nine-provider collection. Quote-only products remain quote-only, and public prices apply only to the stated unit and billing basis. A public consumer subscription, a research allowance, an API report and an institutional seat are not converted into a false like-for-like price.

A feature matrix should describe fit, not award invented scores

The matrix below maps documented product emphasis. “Core” means central to the reviewed proposition; “available” means the provider describes the capability but depth or entitlement must be confirmed; “adjacent” means the category is not the product’s primary job. It is not a score, test result or promise of equivalent coverage.

Interpretation: a buyer can legitimately use more than one layer. A markets team might retain a workstation for listed securities while using a registry-led source to resolve private legal entities and a focused analysis tool to document financial conclusions. The architecture is defensible only if duplicated costs, data lineage and decision ownership are explicit.

Weight the decision before the demonstrations begin

Teams often let the most polished demonstration redefine the problem. A buyer-owned evaluation prevents that. The fictional example below assigns 30% to public-market data, 20% to private-company evidence, 20% to analyst workflow, 15% to delivery and rights, and 15% to governance and support. The weights sum to 100%; no vendor is scored.

Interpretation: weighting is useful only after rejection gates are set. If a provider fails the required exchange, entity-match, source-date, security or permitted-use condition, a strong score elsewhere should not compensate. Conversely, a capability that is genuinely optional should not be presented as mandatory merely because one platform demonstrates it well.

Use real work. Include liquid and thinly traded securities, renamed issuers, dual listings, corporate actions, private subsidiaries, companies with limited disclosure and entities from difficult jurisdictions. Keep the sample fixed across providers. Record both the correct result and the analyst time required to reach it.

Compare annual operating cost, not the visible subscription alone

A quote can combine users, applications, exchange fees, datasets, feeds, APIs, implementation and support. Consumer products may publish simple annual amounts, while enterprise services price a tailored scope. These are valid commercial models, but they cannot be plotted on one honest list-price chart when the units differ or the amounts are not public.

Use a buyer-owned total-cost model. The fictional scenarios below both process 2,000 research cases per year. Scenario A has a £24,000 platform and data cost, £8,000 implementation amortization and 350 review hours at £60, producing 1,450 accepted cases. Scenario B costs £42,000 for platform and data, £4,000 implementation amortization and 160 review hours, producing 1,760 accepted cases. No named provider is assigned either scenario.

Interpretation: a higher subscription can still produce a lower cost per accepted case if it reduces exception work without weakening the evidence standard. That is a hypothesis to test, not a promised saving. Lock the acceptance definition before reviewing results, count failed entity matches and missing fields, and do not remove difficult cases to improve the denominator.

For a three-year comparison, request fees in the contract currency for every mandatory component. State annual indexation, exchange and third-party pass-throughs, implementation, training, support, storage, API overages, additional environments, renewal notice and exit assistance. Model cash payment dates separately from accounting amortization. A discounted first year can conceal a more expensive steady state.

A sceptical enterprise procurement test

Map entitlements to tasks. Ask each provider to identify the application, dataset and right behind every mandatory workflow. “Available on the platform” is not the same as included. Require a sample order form or entitlement schedule and reconcile it with the demonstration. Note which functions depend on third-party exchange or research agreements.

Test source and time semantics. A price needs market, currency, timestamp and adjustment method. A financial statement needs entity, period, currency, units, consolidation basis and filing date. An estimate needs contributor population and update logic. A private-company value needs a clear label distinguishing reported facts from calculated or estimated outputs. Reject silent substitution across these categories.

Test Excel and models under failure. Refresh a representative workbook, change identifiers, simulate unavailable fields and check whether stale values remain visible. Measure formula portability, audit trail, link repair and the work required to leave the platform. A model that updates smoothly in a demonstration can still create serious operational risk if entitlements change or identifiers are proprietary.

Test delivery rights separately. Screen access, spreadsheet export, API retrieval, internal model use, storage, use with language models, customer display and redistribution are distinct permissions. Ask who owns derived outputs, what must be deleted at termination and whether historical reports may be retained for audit. Technical access never proves contractual permission.

Test resilience and support. Define severity levels, response targets, planned maintenance, incident communication, recovery objectives and named escalation routes. Ask how a feed correction reaches downstream models and whether prior values can be reconstructed. For a critical workflow, document the manual fallback before signing.

Run a parallel pilot. Keep the incumbent while finalists process the same real cases. Record disagreements, source dates, missing values, analyst interventions and downstream failures. An attractive interface is not evidence that portfolio coverage or data rights fit. Preserve the existing workflow until acceptance, training, rollback and record-retention controls have passed.

The latest industry developments reinforce this direction. On 20 October 2026 FactSet announced a partnership with Nasdaq Private Market to integrate capitalization-table data. LSEG’s October 2026 Workspace updates added natural-language equity market analytics, and both firms continue expanding governed AI delivery. These developments can be useful, but they make entitlement, source traceability and permitted model use more important—not less.

For focused company analysis, compare a sample Veripoint report with your current output and verify entity-level coverage. For other institutional platforms, review the Capital IQ alternatives and PitchBook competitors guides without assuming their public-market and private-capital categories are identical.

Official product, pricing and update pages checked 21 October 2026. Documented capabilities are not independent performance results. Amounts apply only to the stated unit, billing basis and displayed currency notation; unknown package terms require confirmation. Illustrative weights and costs are not vendor quotations, product scores, investment results or savings forecasts.